prostateview
Teaching concept only — not for diagnosis, PI‑RADS scoring, biopsy planning, or intra-operative navigation. How to use it safely.
← All modules
Module 10

From result to plan

Risk stratification, the MDT, treatment options, and communicating results with empathy.

The last module closes the loop: from the report on the screen to a plan, and to a conversation with a real, anxious human being. This is where it all becomes care.

MRI slices live

The raw multi-parametric scan.

3D reconstruction live

Segmented gland, zones and lesion as a rotatable model.

Beside-patient spatial teaching future spatial workflow

Future spatial-computing workflows for placing the anatomy model in clinical space.

01 Reading the report 4 min

Pull out the key numbers: the ISUP grade, how many cores are positive and the maximum length involved, and the stage. Combined with the PSA, these sort the patient into a risk group, low, intermediate or high.

Key point Risk group comes from PSA, ISUP grade and stage together, not any one alone.
You can read a report and place a patient in a risk category.

Which combine to give the risk group?

02 The MDT and the options 4 min

The MDT matches risk to options:

  • active surveillance: for low-risk and some favourable intermediate-risk disease.
  • Radical treatment: surgery or radiotherapy.
  • Focal therapy in selected cases, and watchful waiting where treatment would not benefit.
You can list the management options and roughly who they suit.

Low-risk localised disease is often managed by?

03 Breaking the news 4 min

However good your pathway, the patient remembers the conversation. Use clear language, avoid jargon, give time and silence, check understanding, and back it up with written information and support contacts.

Hold this Clear words, unhurried time, written backup, a way to ask more later.
You can deliver a diagnosis with clarity and kindness.

Best practice when giving a cancer diagnosis includes?

04 When the biopsy is negative 4 min

A negative biopsy with a suspicious MRI is not a clean all-clear. Do not simply discharge a man with a PI-RADS 5 lesion and negative cores. Consider repeat or more targeted sampling, continued PSA monitoring, and MDT review.

Do not over-reassure Suspicious MRI plus negative cores can mean the lesion was missed, not absent.
You know that a negative result still needs judgement. End of the curriculum.

Negative cores but a PI-RADS 5 lesion. The right approach?

That is the whole curriculum. You can now take a man from a raised PSA, through imaging and biopsy, to a plan and a humane conversation. Genuinely well done.